Inventor

ANNE-MARIE BEAUSOLEIL

Inventor
US

Overview

9→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 9 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C30BSingle-crystal growth3%

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to THERAVANCE BIOPHARMA R&D IP LLC (4)· patent assignee history
2022Patents assigned to ANGEL PHARMACEUTICAL CO LTD (1)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to NEUMORA THERAPEUTICS INC (2)· patent assignee history
2024Patents assigned to CORVUS PHARMACEUTICALS INC (1)· patent assignee history
2025Patents assigned to UNITY BIOTECHNOLOGY INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
THERAVANCE BIOPHARMA R&D IP LLC42022–2025
NEUMORA THERAPEUTICS INC22024–2025
ANGEL PHARMACEUTICAL CO LTD12022
CORVUS PHARMACEUTICALS INC12024
UNITY BIOTECHNOLOGY INC12025
Locations
LocationPatentsSpan
US92022–2025